CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 94 filers reported holding CUE BIOPHARMA INC in Q3 2020. The put-call ratio across all filers is 0.71 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $67,562 | -49.4% | 18,510 | +56.7% | 0.00% | 0.0% |
| Q4 2021 | $133,605 | +44.5% | 11,813 | +86.1% | 0.00% | 0.0% |
| Q3 2021 | $92,476 | -38.5% | 6,347 | -50.8% | 0.00% | 0.0% |
| Q2 2021 | $150,413 | -4.5% | 12,911 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $157,514 | -1.8% | 12,911 | +0.7% | 0.00% | -50.0% |
| Q4 2020 | $160,416 | -16.9% | 12,823 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $192,986 | -38.6% | 12,823 | 0.0% | 0.00% | -50.0% |
| Q2 2020 | $314,292 | +121.4% | 12,823 | +28.2% | 0.00% | +100.0% |
| Q1 2020 | $141,985 | -10.6% | 10,006 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $158,845 | – | 10,006 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Corriente Advisors, LLC | 1,437,445 | $21,634,000 | 10.97% |
| Prosight Management, LP | 709,936 | $10,685,000 | 5.08% |
| Voss Capital, LLC | 226,573 | $3,410,000 | 1.94% |
| Robertson Stephens Wealth Management, LLC | 484,000 | $7,284,000 | 1.79% |
| Slate Path Capital LP | 1,483,619 | $22,328,000 | 1.27% |
| Nantahala Capital Management | 2,342,216 | $35,250,000 | 1.08% |
| SANDERS MORRIS HARRIS LLC | 142,430 | $2,312,000 | 0.63% |
| Rock Creek Group, LP | 80,000 | $1,204,000 | 0.62% |
| PRECEPT MANAGEMENT LLC | 150,000 | $2,258,000 | 0.55% |
| PA Capital LLC | 46,850 | $705,000 | 0.50% |